The impact of perceived treatment assignment on smoking cessation outcomes among African-American smokers

Journal of General Internal Medicine

Volumn 23, Issue 9, 2008, Pages 1361-1366

  Thomas, Janet L ^a   Guo, Hongfei ^b   Lynam, Ian M ^c   Powell, Joshua N ^d   Okuyemi, Kolawole S ^b   Bronars, Carrie A ^e   Ahluwalia, Jasjit S ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^e UNIVERSITY OF KANSAS   (United States)

Author keywords

African American; Bupropion; Expectation bias; Placebo effect; Smoking cessation

Indexed keywords

AMFEBUTAMONE; CARBON MONOXIDE; COTININE; PLACEBO;

ADULT; AFRICAN AMERICAN; ARTICLE; CHI SQUARE TEST; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EDUCATIONAL STATUS; FEMALE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTIVE VALIDITY; RANDOMIZED CONTROLLED TRIAL; RISK; SELF REPORT; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

ADULT; AFRICAN AMERICANS; BUPROPION; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCEPTION; PLACEBO EFFECT; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 50049130177     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-008-0656-3     Document Type: Article

References (33)

1. SR Sutton 1991 Great expectations: some suggestions for applying the balanced placebo design to nicotine and smoking. [Review] [8 refs] Br J Addict. 86 659 662
2. S Stewart-Williams J Podd 2004 The placebo effect: dissolving the expectancy versus conditioning debate.[see comment] Psychol Bull. 130 324 340
3. Kirsch I. Specifying nonspecifics: Psychological mechanisms of placebo effects. In: Harrington A, ed. The placebo effect: an interdisciplinary exploration. Cambridge: Harvard University Press; 1997:166-86.
4. K Perkins M Sayette C Conklin A Caggiula 2003 Placebo effects of tobacco smoking and other nicotine intake Nicotine Tob Res 5 695 709
5. S Stewart-Williams 2004 The placebo puzzle: putting together the pieces Health Psychol 23 198 206
6. JR Hughes D Krahn 1985 Blindness and the validity of the double-blind procedure J Clin Psychopharmacol 5 3 138 142
7. M Mooney T White D Hatsukami 2004 The blind spot in the nicotine replacement therapy literature: assessment of the double-blind in clinical trials. [Review] [49 refs] Addict Behav 29 4 673 684
8. SM Hall GL Humfleet VI Reus 2002 Psychological intervention and antidepressant treatment in smoking cessation Arch Gen Psychiatry 59 930 936
9. JD Killen SP Fortmann GM Murphy Jr. 2006 Extended treatment with bupropion SR for cigarette smoking cessation J Consult Clin Psychol 74 286 294
10. JD Killen TN Robinson S Ammerman 2004 Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers J Consult Clin Psychol 72 729 735
11. EJ Wagena PG Knipschild MJ Huibers EF Wouters CP van Schayck 2005 Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease Arch Intern Med 165 2286 2292
12. JA Simon C Duncan TP Carmody ES Hudes 2004 Bupropion for smoking cessation: A randomized trial Arch Intern Med 164 1797 1803
13. USDHHS. Tobacco use among U.S. racial ethnic minority groups African Americans, American Indians, and Alaskan Natives, Asian Americans, and Pacific Islanders and Hispanics: A report of the surgeon general (Washington, D.C., Government Printing Office). 1998.
14. USDHHS. Healthy people 2010: Objectives for improving health (Washington, DC). 2000.
15. C Lerman V Kaufmann M Rukstalis 2004 Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial Ann Intern Med 140 426 433
16. LL Pederson JS Ahluwalia KJ Harris GA McGrady 2000 Smoking cessation among African Americans: what we know and do not know about interventions and self-quitting Prev Med 31 23 38
17. JM Royce N Hymowitz K Corbett TD Hartwell MA Orlandi 1993 Smoking cessation factors among African Americans and Whites Am J Public Health 83 220 226
18. National Cancer Institute. Population Based Smoking Cessation: Proceedings of a Conference on What Works to Influence Cessation in the General Population. Smoking and Tobacco Control Monograph No. 12. (Bethesda, MD., Department of Health And Human Services, National Institutes of Health, National Cancer Institute). 2000
19. LP Hahn AR Folsom JM Sprafka SW Norsted 1990 Cigarette smoking and cessation behaviors among urban blacks and whites Public Health Rep 105 290 295
20. GA Giovino MW Schooley BP Zhu JH Chrismon SL Tomar JP Peddicord RK Merritt CG Husten MP Eriksen 1994 Surveillance for selected tobacco-use behaviors-United States, 1900-1994 Morb Mortal Wkly Rep CDC Surveill Summ 43 1 43
21. MC Fiore TE Novotny JP Pierce 1989 Trends in cigarette smoking in the U. S. - the changing influence of gender and race JAMA 261 49 55
22. DR Trinidad EA Gilpin MM White JP Pierce 2005 Why does adult African-American smoking prevalence in California remain higher than for non-Hispanic whites? Ethn Dis 15 505 511
23. GC Kabat A Morabia EL Wynder 1991 Comparison of smoking habits of blacks and whites in a case-control study Am J Public Health 81 1483 1486
24. NL Benowitz 1996 Cotinine as a biomarker of environmental tobacco smoke exposure Epidemiol Rev 18 188 204
25. PI Clark S Gautam LW Gerson 1996 Effect of menthol cigarettes on biochemical markers of smoke exposure among black and white smokers Chest 110 1194 1198
26. KS Okuyemi JS Ahluwalia KP Richter MS Mayo K Resnicow 2001 Differences among African American light moderate and heavy smokers Nicotine Tob Res 3 49 54
27. JS Ahluwalia KJ Harris D Catley KS Okuyemi MS Mayo 2002 Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial J Am Med Assoc 288 468 474
28. NA Desbiens 2002 In randomized controlled trials, should subjects in both placebo and drug groups be expected to guess that they are taking drug 50% of the time? Med Hypotheses 59 227 232
29. TJ Kaptchuk 1998 Powerful placebo: the dark side of the randomised controlled trial Lancet 351 1722 1725
30. AK Shapiro 1969 Iatroplacebogenics Int Pharacopsychiatry 2 215
31. AK Shapiro 1964 Placebogenics and iatroplacebogenics Med Times 92 1037 1043
32. JA Turner RA Deyo JD Loeser M Von Korff WE Fordyce 1994 The importance of placebo effects in pain treatment and research Jama 271 1609 1614
33. TF Heatherton LT Kozlowski RC Frecker KO Fagerstrom 1991 The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire Br J Addict 86 1119 1127